JPMORGAN CHASE & CO - DECIBEL THERAPEUTICS INC ownership

DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of DECIBEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$450,377
+18.8%
116,981
-6.9%
0.00%
Q1 2023$379,000
+141847.6%
125,661
-3.8%
0.00%
Q4 2022$267
-99.9%
130,572
-8.2%
0.00%
Q3 2022$492,000
-21.2%
142,259
-4.0%
0.00%
Q2 2022$624,000
+31.1%
148,224
-5.2%
0.00%
Q1 2022$476,000
-36.2%
156,369
-2.6%
0.00%
Q4 2021$746,000
-41.5%
160,525
-2.9%
0.00%
Q3 2021$1,275,000
-31.6%
165,369
-23.7%
0.00%
Q2 2021$1,863,000
-32.7%
216,722
-11.1%
0.00%
Q1 2021$2,770,000243,8280.00%
Other shareholders
DECIBEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATLAS CAPITAL ADVISORS LLC 40,000$36,4000.01%
View complete list of DECIBEL THERAPEUTICS INC shareholders